SUBSTANCE EXPOSED INFANTS PRESENTED BY ECOLE J. BARROW-BROOKS M.ED & DARLENE D. OWENS MBA, LBSW, CADC, ADS

Similar documents
Emergent Issues Affecting Early Intervention/ Early Childhood. Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC

Neonatal Abstinence Syndrome Epidemiology, diagnosis, management and prevention

Opioid Use Disorder in Pregnancy. Neonatal Abstinence Syndrome

The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome

Care of the Neonate with Prenatal Opioid Exposure. Objectives. What is Neonatal Abstinence Syndrome (NAS)/ Neonatal Opiate Withdrawal Syndrome?

Understanding Prenatal Drug Exposure

Objectives. Care of the Neonate with Prenatal Opioid Exposure. What is Neonatal Abstinence Syndrome (NAS)? Increasing Incidence of NAS 8/27/2016

Product Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD

Presented by DCF SunCoast Region: Kyle Teague, Melissa Worthen, Christina Cuoco, Nina Romeu, Dekesha Seay

Safe Babies Foster Parent Training Program

Neonatal Drug Withdrawal

Relationships Relationships

Understanding Prenatal Alcohol Exposure

Understanding the Impact of Drugs on Children. Jackie McReynolds Washington State University

FETAL ALCOHOL SPECTRUM DISORDERS (FASDs)

Consequences and Treatment of Opioid Abuse During Pregnancy. Katie Ellis, PharmD March 12, 2018

Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC.

Lori A. Shook, MD Division of Neonatology Kentucky Children s Hospital University of Kentucky Medical Center

Remote Alcohol & Other Drugs Workforce Northern Territory. Fetal Alcohol Spectrum Disorder (FASD) Footprints across the Territory 1

Wales Neonatal Network Guideline

Opioid Use in Pregnant Women and Prenatal Care. Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard

Neonatal abstinence syndrome

Birth mother Foster carer Other

1/26/2018 PREVENTING THE RETRAUMITIZATION OF CHILDREN FROM ADDICTED FAMILIES THE PROBLEM RISK FACTORS FOR ENDANGERMENT

WHO International Collaborative Research Project on Child Development and Prenatal Risk Factors with a Focus on FASD. Dr V. Poznyak and Mr Dag Rekve

Objectives. Common Drugs leading to NAS. Differential Diagnosis. Clinical Features of NAS. Assessing Neonatal Abstinence in the Newborn Nursery

Section F: Discussing the diagnosis and developing a management plan

Teresa s Background. Close Family. Sources. The Faces of FASD. Today We Will Learn About


Part 2 Who Is at Risk? What Does FASD Look Like? FASD Diagnostic Guidelines. Common Challenges Across the Spectrum

Dilaudid, a narcotic analgesic, is prescribed for the relief of moderate to severe pain such as that due to:

4 th Annual Conference 9 September Karen Kuehn Howell, Ph.D. Emory University

Outcomes of Infants with Neonatal Abstinence Syndrome

Fetal Alcohol Exposure

Marijuana During Pregnancy: An Overview

Unifying Efforts to Eliminate Perinatal Substance Use in Santa Clara County

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Inequalities in health and their effect on the newborn

Prenatal Substance Abuse: Improving Outcomes

Neonatal Abstinence: It s No Child s Play!

8/24/2015 ADDICTION AND PREGNANCY. Fear ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY

Production by. Faculty Disclosure. Program Objectives. Accreditation. Methamphetamine Use: Maternal, Fetal and Neonatal Effects

When you drink, your baby drinks too. Drinking alcohol during

Substance Use During Pregnancy. I have no conflicts of interest or relevant financial relationships with any commercial entities.

Addiction and Pregnancy. Jim Walsh, MD Medical Director Addiction Recovery Service Swedish Medical Center WSADCP October 2018

The Impact of the Opioid Crisis on Children

FDA APPROVED MEDICATION GUIDE

UNIVERSITY OF WASHINGTON

FASD: What is it? When and How to Start the Conversation. Kathy Hotelling, Ph.D., ABPP

INITIAL PATIENT INTAKE FORM

2/28/2017. Substance Use Disorders + Pregnancy. Substance Use Disorders + Pregnancy. + Prevalence of the Problem

Common Drugs of Abuse. Tobacco/Nicotine Cannabis Alcohol Opiates Cocaine Methamphetamine. 36 weeks gestation adult

Medication Guide Clonazepam Tablets USP (kloe-na-za-pam)

Brain Development and the Impact of Trauma

MEDICATION GUIDE Morphine Sulfate (MOR feen SUL fate) (CII) Oral Solution

Neonatal Abstinence Syndrome:

9TH ANNUAL MENTAL HEALTH RECOVERY CONFERENCE 2015

Marijuana in the Obstetric Population

New Patient Information Form

MEDICATION GUIDE Morphine Sulfate (mor-pheen) (CII) Oral Solution

Prenatal Substance Exposure: Maternal Screening and Neonatal Identification and Management Ira J. Chasnoff. DOI: /neo.

MEDICATION GUIDE MORPHINE Sulfate Oral Solution (mor-pheen) CII Rx only

MEDICATION GUIDE Valproic Acid (val pro ic acid) Capsules

What is the most important information I should know about Morphine Sulfate Oral Solution?

Drug Endangered Babies: The Impact of Prenatal Substance Abuse on Pregnancy & Beyond

Understanding FASD in the Context of Other Drug Use and Pregnancy

Fetal Alcohol Spectrum Disorder (FASD)

HD CLINIC MEDICAL HISTORY FORM

PATIENT INFORMATION NARCAN (nar kan) (naloxone hydrochloride) Nasal Spray

IMPORTANT: PLEASE READ READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PART III: PATIENT MEDICATION INFORMATION

Depression in Pregnancy

MEDICATION GUIDE Oxycodone Hydrochloride (ox-ee-co-dohn) (CII) Oral Solution, USP

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. (Pentazocine Lactate Injection, USP)

Substance-Exposed Newborn

Funding for TIPS provided by: The State of Tennessee Portions of this presentation 2002 The American College of Obstetricians and Gynecologists

NEONATOLOGY Healthy newborn. Neonatal sequelaes

Methadone and Pregnancy

SAMHSA FASD Center for Excellence

Venlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including:

Department of Psychiatry\Behavioral Health 200 Mercy Drive, Suite 201 Dubuque, IA or

American Academy of Pediatrics 2014 Educational Webinar Series Monday, July 28, 3:00 3:30 pm ET

Supplementary Appendix

MOSBIRT - Personal Health Risk Assessment

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

And Then There Were Two. Renae Buehner RNC, BSN Avera McKennan Labor and Delivery Unit Supervisor, Lead OB Flight RN

Patient s Name: Birthdate: (dd/mm/yyyy) Sex: Mailing Address: Phone Number: Family Doctor or Paediatrician. How did you hear about the clinic?

Facts About Alcohol. 2.1 million students between the ages of drove under the influence of alcohol last year

Contact: Daina Basile FOR IMMEDIATE RELEASE Kovak-Likly Communications ,

The high risk neonate

Avicenna Acupuncture PEDIATRIC INTAKE FORM (BIRTH TO 5 YEARS)

PAGE 1 NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only)

Addiction Across the Lifespan

Substance-Exposed Newborns

Effects of Prenatal Illicit Drug. Use on Infant and Child

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION

IN-PATIENT PEDIATRIC REHABILITATION

MEDICATION GUIDE. The risk of getting a serious skin rash is higher if you:

DIVALPROEX (di val pro ex) SODIUM DELAYED-RELEASE TABLETS, USP

Susan M. Stephens, MD, FAAP Medical Director Comprehensive Medical and Dental Program Arizona Department of Child Safety

MEDICATION GUIDE CODEINE SULFATE (koh-deen) CII Oral Solution

Transcription:

SUBSTANCE EXPOSED INFANTS PRESENTED BY ECOLE J. BARROW-BROOKS M.ED & DARLENE D. OWENS MBA, LBSW, CADC, ADS 1

SUBSTANCE-EXPOSED INFANTS Refers to infants exposed to alcohol and or other substances ingested by the mother in utero, whether or not this exposure is detected. 2

SUBSTANCE-EXPOSED INFANTS Prenatal exposure to alcohol, tobacco and illicit drugs has the potential to cause physical, emotional and developmental problems for infants. 3

FRAMING THE ISSUE 400,000-440,000 infants (10% -11% of all births) are affected by prenatal alcohol or illicit drug exposure The harm caused to the child can be significant and long-lasting Prenatal substance exposure s effects on the developing brain affect cognitive abilities Global deficits (developmental delays, intellectual disability) Borderline cognitive abilities Pockets of intellectual deficits Widely varying abilities 4

ALCOHOL EXPOSURE Fetal Alcohol Syndrome (FAS), the leading and only preventable cause of birth defects and developmental disabilities. Adverse effects of FAS may include: Reduced growth Behavioral or cognitive disabilities Central nervous system abnormalities Heart, bone, kidney or eye defects Hearing loss Dysmorphic features 5

ALCOHOL EXPOSURE CONT. Withdrawal from alcohol during the first 12 hours after birth, which may include: Tremors Poor feeding patterns, including weak sucking or exaggerated mouthing Poor sleeping Excessive crying 6

FETAL ALCOHOL SPECTRUM DISORDERS (FASD) Umbrella term for the range of effects that can occur with prenatal alcohol exposure Diagnostic terms include: Fetal alcohol syndrome Partial fetal alcohol syndrome Alcohol Related Neurodevelopmental Disorder 7

FETAL ALCOHOL SYNDROME Growth delays either at birth or after birth Characteristic facial dysmorphology Central Nervous System Dysfunction Microcephaly (small head size) Intellectual disability Structural changes to the brain Deficits in 3 areas as determined by neuropsychological testing Characteristic facial dysmorphology 8

9

HOW MUCH ALCOHOL CAN A PREGNANT WOMEN DRINK WITHOUT HARMING HER UNBORN BABY? A. One drink a day B. One drink a month C. A few drinks with friends on a weekend in the 6th month D. None 10

ANSWER: D. None 11

MARIJUANA EXPOSURE This is the most commonly used illicit drug during pregnancy. Overall use by expecting mothers in the U.S. population is between 4.8 % & 5.4 %. Limited inconclusive studies have been done in this population, but some findings suggest an infant exposed to marijuana is at greater risk for: Withdrawal from marijuana, which may include: Tremors High-pitched crying Abnormal sleep patterns Prolonged startle reflex 12

COCAINE EXPOSURE An infant exposed to Cocaine is at greater risk for multiple deformities, which may include: Genitourinary tract, cranial or heart defects Bowel atresia Upper limb defects Prune belly syndrome Ambiguous genitalia Low birth weight, head circumference & length Meconium Aspiration Syndrome Persistent pulmonary hypertension Strokes, intracranial hemorrhage & infarcts due to precipitous delivery Sudden Infant Death Syndrome (SIDS) 13

WITHDRAWAL FROM COCAINE, WHICH MAY CAUSE: Central Nervous System (CNS) irritability including restlessness, irritability, tremors & increased tone Sleepiness and sluggishness, which may follow CNS irritability Behavioral symptoms, which may include trouble responding to human faces or voices, alternating periods of sleep and agitation, overstimulation, difficulty being consoled, exaggerated startle response, or rapid state changes (for example, when the infant goes from a quiet alert state to crying or crying excessively to sleep) Neuromotor problems such as high or low muscle tone, abnormal movements or abnormal suck-swallow patterns 14

AMPHETAMINE EXPOSURE 1.5% of Americans use amphetamines. Multiple drug use is high in those who use amphetamines. An infant exposed to amphetamines is at greater risk for: Decreased birth weight, head circumference & length Significant complications related to blood loss from placental abruption Possible CNS or heart abnormalities 15

WITHDRAWAL FROM AMPHETAMINES MAY CAUSE: Abnormal sleep patterns, poor feeding, tremors, abnormal weight gain Agitation, vomiting & profuse sweating Frantic fist sucking, high-pitched crying, loose stools, fevers, yawning & increased reflexes. 16

OPIOID EXPOSED INFANTS ARE AT GREATER RISK FOR: Excessive crying/irritability Abnormal coordination between sucking and swallowing Low Apgar scores Decreased or low birth weight, head circumference & length Congenital infections Premature birth and lower birth weight Blotchy skin coloring (mottling) Diarrhea Fever Hyperactive reflexes Increased muscle tone Irritability Poor feeding Rapid breathing Seizures Sleep problems Slow weight gain Stuffy nose, sneezing Sweating Trembling (tremors) Vomiting 17

TOBACCO EXPOSED INFANTS Infants who are exposed to secondhand smoke after birth are also at greater risk for SIDS. Chemicals in secondhand smoke appear to affect the brain in ways that interfere with its regulation of infants' breathing Infants who die from SIDS have higher concentrations of nicotine in their lungs and higher levels of cotinine (a biological marker for secondhand smoke exposure) than infants who die from other causes. 18

SOCIETAL IMPACTS OF PRENATAL SUBSTANCE EXPOSURE Prenatal substance exposure is associated with significant societal financial costs. Neonatal hospital costs for children exposed to Cocaine in-utero are estimated to be $5,200 more than the hospital costs for nonexposed infants. Children that need additional time in the hospital, beyond the point of medical need, but necessary while securing foster care placement, increases the cost by an additional $3,500. 19

TREATMENT DURING PREGNANCY Women with high-risk, drug-exposed pregnancies are shown to adapt to pregnancy and motherhood less easily. These women require specialized services to create nurturing and caring environments for both themselves and their child. Pregnancy-specific treatment programs have been developed to guide the practice of treating substance using mothers and/or mothers-to-be by addressing: Health and nutrition Providing support with the pregnancy 20

BARRIERS TO TREATMENT Low self-esteem Fearfulness of the stigma associated with prenatal drug use Family and work obligations Lack of access to health insurance Substance using or violent partners 21

CONCLUSION Drug use during pregnancy presents continuing costs at the personal, familial and societal level. In-utero drug exposure harms children Intervention effectiveness to assist pregnant substance users Postpartum, mother and child needs established through the following: Solid program evaluation Research Continued governmental support and commitment. 22

QUESTIONS? 23